Can Peijia Medical’s TaurusTrio system finally solve the AR treatment gap in China?
Peijia Medical has received regulatory approval from the National Medical Products Administration of China for the TaurusTrio Transcatheter Aortic Valve system, a dedicated device for the treatment of native symptomatic severe aortic regurgitation. Developed under an exclusive license from JenaValve Technology, the system is based on the latter’s Trilogy Transcatheter Heart Valve platform and represents